INTT vs. ALNT, FEIM, DAIO, VLTO, TER, ITRI, COHU, TRNS, AEHR, and EB
Should you be buying inTEST stock or one of its competitors? The main competitors of inTEST include Allient (ALNT), Frequency Electronics (FEIM), Data I/O (DAIO), Veralto (VLTO), Teradyne (TER), Itron (ITRI), Cohu (COHU), Transcat (TRNS), Aehr Test Systems (AEHR), and Eventbrite (EB).
inTEST (NYSE:INTT) and Allient (NASDAQ:ALNT) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.
inTEST has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500. Comparatively, Allient has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500.
In the previous week, Allient had 3 more articles in the media than inTEST. MarketBeat recorded 4 mentions for Allient and 1 mentions for inTEST. Allient's average media sentiment score of 1.25 beat inTEST's score of 0.00 indicating that Allient is being referred to more favorably in the news media.
63.2% of inTEST shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 5.5% of inTEST shares are held by company insiders. Comparatively, 15.6% of Allient shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
inTEST currently has a consensus target price of $16.00, suggesting a potential upside of 46.79%. Allient has a consensus target price of $39.50, suggesting a potential upside of 37.06%. Given inTEST's stronger consensus rating and higher probable upside, equities analysts plainly believe inTEST is more favorable than Allient.
inTEST received 6 more outperform votes than Allient when rated by MarketBeat users. However, 66.67% of users gave Allient an outperform vote while only 61.54% of users gave inTEST an outperform vote.
Allient has higher revenue and earnings than inTEST. inTEST is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.
inTEST has a net margin of 6.41% compared to Allient's net margin of 4.26%. Allient's return on equity of 15.26% beat inTEST's return on equity.
Summary
Allient beats inTEST on 9 of the 17 factors compared between the two stocks.
Get inTEST News Delivered to You Automatically
Sign up to receive the latest news and ratings for INTT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INTT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
